课题基金 / 基金详情

LANSOPRAZOLE IN PEDIATRIC PATIENTS W/ ESOPHAGITIS

LANSOPRAZOLE IN PEDIATRIC PATIENTS W/ ESOPHAGITIS
兰索拉唑治疗儿童食管炎患者
批准号：
6308594
负责人：
MELVIN B. HEYMAN
金额：
$1.75万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-12-01 至 2000-11-30
来源：
https://reporter.nih.gov/project-details/6308594
关键词：
age difference antiulcer drug child (0-11) clinical research clinical trial phase I dosage drug screening /evaluation gastrointestinal disorder chemotherapy human subject human therapy evaluation pharmacokinetics reflux esophagitis

项目摘要

项目成果

MELVIN B. HEYMAN的其他基金

相关文献

中文摘要
翻译
这项研究将验证兰索拉唑将被证明是安全有效的治疗儿童症状性胃食道反流病和糜烂性食管炎患者的假设。次要目标是比较成人的药代动力学特征，并为儿科患者提供给药建议。
英文摘要
This study will test the hypothesis that lansoprazole will prove to be safe and effective in the treatment of pediatric patients with symptomatic gastroesophageal reflux disease and erosive esophagitis. Secondary objectives are to compare the pharmacokinetic profile to that obtained in adults and to provide dosing recommendations for pediatric patients
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies in Children with Digestive Disorders
INTESTINAL FUNCTION AND LINEAR GROWTH IN CROHN'S DISEASE: EFFECT OF GH
PHENOTYPIC EXPRESSION OF FAP GENE MUTATIONS IN CHILDREN AND ADOLESCENTS
Intestinal function and linear growth in Crohn's disease: effect of GH